India’s Pioneering Advancements in Vaccinology: Challenges and Milestones – Part 2

Year : 2026 | Volume : 16 | 02 | Page :
    By

    Vibha Gupta,

  • Maitry Goel,

  1. Professor, Department of Biotechnology, Jaypee Institute of Information Technology, Sector 62, Noida, Uttar Pradesh, India
  2. Student, Department of Biotechnology, Jaypee Institute of Information Technology, Sector 62, Noida, Uttar Pradesh, India

Abstract

India has become a global leader in vaccinology, playing a vital role in developing, producing, and distributing vaccines that protect millions of lives. By embracing advances in molecular immunology, recombinant antigen technology, and virus-like particle (VLP) platforms, the country has created affordable vaccines against major diseases, including poliovirus, rotavirus, and SARS-CoV-2. National initiatives, like Mission Indradhanush and Vaccine Maitri, have helped expand immunization coverage, improve public health, and share vaccines with countries in need, reflecting India’s commitment to both national and global health. The development of homegrown vaccines, such as Shanvac-B, showcases how cutting-edge biotechnology can be translated into practical solutions that make a real difference in people’s lives. Strong regulatory frameworks, including the New Drugs and Clinical Trials Rules (2019) and rigorous chemistry, manufacturing, and controls (CMC) standards, ensure that every vaccine is safe, effective, and capable of generating a strong immune response. Innovations in adjuvants, high-yield production methods, and public–private collaborations have further strengthened India’s position in global immunization efforts. With experience in large-scale vaccination drives, research on novel vaccine platforms, and efficient distribution systems, the country is well-prepared to respond swiftly to new health threats. As infectious diseases continue to emerge and public health challenges evolve, India’s dedication to scientific innovation, strategic planning, and international collaboration will remain essential to safeguard communities, enhance long-term resilience, and ensure a healthier future for people both within the country and around the world

Keywords: Immunogenicity, Mission Indradhanush, SARS-CoV-2, Shanvac-B, Vaccine Maitri

How to cite this article:
Vibha Gupta, Maitry Goel. India’s Pioneering Advancements in Vaccinology: Challenges and Milestones – Part 2. Research and Reviews: A Journal of Microbiology and Virology. 2026; 16(02):-.
How to cite this URL:
Vibha Gupta, Maitry Goel. India’s Pioneering Advancements in Vaccinology: Challenges and Milestones – Part 2. Research and Reviews: A Journal of Microbiology and Virology. 2026; 16(02):-. Available from: https://journals.stmjournals.com/rrjomv/article=2026/view=238856


References

  1. Plotkin S. History of vaccination. Proc Natl Acad Sci U S A. 2014 Aug;111(34):12283–12287. doi: 1073/pnas.1400472111. Available from: https://doi.org/10.1073/pnas.1400472111. Accessed 30 Apr 2025.
  2. Khatri SA. Insights into India’s expanding global vaccine production. Think Global Health. Available from: https://www.thinkglobalhealth.org/article/insights-india-expanding-global-vaccine-production.
  3. Vaccines in India – pharmaceuticals industry. Statista. 2025. Available from: https://www.statista.com/outlook/hmo/pharmaceuticals/vaccines/india?currency=USD. Accessed 14 Apr 2025.
  4. Salalli R, Dange JR, Dhiman S, Sharma T. Vaccines development in India: Advances, regulation, and challenges. Clin Exp Vaccine Res. 2023 Jul;12(3):193–208. doi: 7774/cevr.2023.12.3.193.
  5. Tahamtan A, Charostad J, Hoseini Shokouh SJ, Barati M. An overview of history, evolution, and manufacturing of various generations of vaccines. J Arch Mil Med. 2017;5:e12315.
  6. Ministry of Health and Family Welfare. Annual report 2016–17: Organization and infrastructure. New Delhi: Ministry of Health and Family Welfare; 2018. Available from:https://main.mohfw.gov.in/sites/default/files/1201617.pdf.
  7. Howard N, Walls H, Bell S, Mounier-Jack S. The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda. Vaccine. 2018;36(39):5536–5543. doi: 1016/j.vaccine.2018.07.046.
  8. Sathiaraj E. Better nutrition for a better future. Geneva: James Lind Institute; 2021. Available from: https://www.jli.edu.in/blog/roles-and-responsibilities-ofcdsco.
  9. Indian Council of Medical Research. Announcement: Indian Council of Medical Research reference list. New Delhi: Indian Council of Medical Research; 2017. Available from: http://www.icmr.nic.in/.
  10. Kadam R, Karandikar S. Ethics committees in India: Facing the challenges. Perspect Clin Res. 2012;3(2):50–56. doi: 4103/2229-3485.96446.
  11. World Health Organization. Research ethics committees: basic concepts for capacity-building. Geneva: World Health Organization; 2009.
  12. National Health Mission. Immunization: National Health Mission. Available from: https://nhm.gov.in.
  13. Press Information Bureau. Shri J P Nadda launches pneumococcal conjugate vaccine (PCV) under universal immunization programme (UIP). 2017 May 30. Available from: https://pib.nic.in.
  14. Patra N. Universal immunization programme in India: The determinants of childhood immunization [PDF]. Calcutta: Indian Statistical Institute; 2012.
  15. Chatterjee S, Pant M, Haldar P, Aggarwal MK, Laxminarayan R. Current costs and projected financial needs of India’s universal immunization programme. Indian J Med Res. 2016;143(6):801–808. doi: 4103/0971-5916.192073.
  16. Polio Global Eradication Initiative. Archived information. 2012 Dec 22.
  17. The Hindu. Mumbai child becomes fourth Indian to get polio from vaccine. The Hindu. 2015 Jan 2.
  18. Wikipedia contributors. Mission Indradhanush. Wikipedia. Available from: https://en.wikipedia.org/wiki/Mission_Indradhanush.
  19. Press Information Bureau. Intensified Mission Indradhanush (IMI) 5.0 campaign concludes all three rounds on 14 Oct 2023. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1966931. Accessed 30 Apr 2025.
  20. The Hindu Business Line. Vaccine Maitri: A sanjeevini for the world. The Hindu Business Line. 2021 Mar 4.
  21. Ministry of External Affairs – Government of India. Available from: https://www.mea.gov.in.
  22. BBC News. Coronavirus: India temporarily halts Oxford-AstraZeneca vaccine exports. BBC News. 2021 Mar 24.
  23. BBC News. COVID vaccine: India to resume vaccine exports from October. BBC News. 2021 Sep 21.
  24. N India pledges support to UN to ensure Syria gets COVID vaccines. NDTV. 2021 Mar 23.
  25. India’s ‘gift’ to UN peacekeepers: 200,000 COVID vaccine doses. Mint. 2021 Mar 26.
  26. Ravelo JL. The evolution of global health’s ‘best-kept secret’. Devex. 2014 Nov 10.
  27. World Health Organization. GAVI – The global alliance for vaccines and immunizations. WHO. 2022 Apr 5.
  28. Ikilezi G, Augusto OJ, Dieleman JL, Sherr K, Lim SS. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage. Vaccine. 2020;38(3):588–596. doi: 1016/j.vaccine.2019.10.057.
  29. Jaupart P, Dipple L, Dercon S. Has Gavi lived up to its promise? BMJ Glob Health. 2019;4(6):e001789. doi: 1136/bmjgh-2019-001789.
  30. Tsai FJ, Lee H, Fan VY. Perspective and investments in health system strengthening of Gavi, the vaccine alliance. Int Health. 2016;8(4):246–252. doi: 1093/inthealth/ihv063.
  31. Paulson T. Doctors without borders criticizes Gates-backed global vaccine strategy. Humanosphere. 2012 May 15.
  32. Doctors Without Borders – USA. Pneumococcal vaccine is launched in Africa, but are donors getting a fair deal from companies? Available from: https://www.doctorswithoutborders.org.
  33. Storeng KT. The GAVI alliance and the ‘Gates approach’ to health system strengthening. Glob Public Health. 2014;9(8):865–879. doi: 1080/17441692.2014.940362.
  34. Directorate General of Health Services. National tuberculosis elimination programme. Ministry of Health and Family Welfare, Government of India. Available from: https://dghs.mohfw.gov.in/national-tuberculosis-elimination-programme.php.
  35. Ministry of Health and Family Welfare, Government of India. India’s immunization drive: A commitment to universal vaccine coverage and health equity. Press release; Apr 2025.
  36. Havisure – India’s first indigenously developed hepatitis A vaccine. 2024 Jan 22.
  37. Shantha Biotechnics. Shanvac-B. Available from: https://shanthabiotech.com/shanvac_b.asp.
  38. Serum Institute of India Pvt Ltd. Pentavac (PFS/SD) – diphtheria, tetanus, pertussis, hepatitis B and Haemophilus type b conjugate vaccine. Available from: https://www.seruminstitute.com/product_ind_pentavac.php.
  39. Serum Institute of India. CERVAVAC – quadrivalent human papilloma virus vaccine. Available from: https://www.seruminstitute.com/product_ind_cervavac.php.
  40. B
  41. Behera P, Singh AK, Subba SH, Mc MA, Sahu DP, Chandanshive PD, et al. Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India. Hum Vaccin Immunother. 2022;18(1):2034456. doi: 1080/21645515.2022.2034456.
  42. Serum Institute of India Pvt Ltd. COVISHIELD FAQs. 2021 Jul 5. Available from: https://www.seruminstitute.com/health_faq_covishield.php.
  43. Press Information Bureau. Union health minister lists achievements of the union health ministry in the first 100 days of the new government. 2024 Sep 20.
  44. Bharat Biotech. ROTAVAC. Available from: https://www.bharatbiotech.com/rotavac.html.
  45. B. Typbar TCV. Available from: https://www.bharatbiotech.com/typbartcv.html.
  46. Bharat Biotech. COVAXIN. Available from: https://www.bharatbiotech.com/covaxin.html.
  47. W ZyCoV-D. Available from: https://en.wikipedia.org/wiki/ZyCoV-D.
  48. W Corbevax. Available from: https://en.wikipedia.org/wiki/Corbevax.
  49. Bharat Biotech. Intranasal vaccine. Available from: https://www.bharatbiotech.com/intranasal-vaccine.html.
  50. Bharat Biotech. Hillchol. Available from: https://www.bharatbiotech.com/hillchol.html.
  51. Ministry of Science and Technology, Government of India. List of licensed human vaccine manufacturing facilities in India. India Science, Technology & Innovation Portal. Available from: https://www.indiascienceandtechnology.gov.in.
  52. PATH (global health organization). Available from:

https://en.wikipedia.org/wiki/PATH_%28global_health_organization%29.

  1. Indo-Pacific Health Security. Quad vaccine partnership. Department of Foreign Affairs and Trade (DFAT). Available from: https://indopacifichealthsecurity.dfat.gov.au.
  2. Vision IAS. India’s vaccination drives: strategy, obstacles and opportunities. Available from: https://cdn.visionias.in/value_added_material/8d9e6-indias-vaccination-drives_strategy-obstacles-and-opportunities.pdf. 

 

Ahead of Print Subscription Review Article
Volume 16
02
Received 09/12/2025
Accepted 04/01/2026
Published 20/01/2026
Publication Time 42 Days
31

Login


My IP

PlumX Metrics